Cresset Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.88M Sell
56,280
-3,786
-6% -$261K 0.02% 403
2025
Q1
$4.24M Buy
60,066
+3,230
+6% +$228K 0.02% 367
2024
Q4
$4.89M Sell
56,836
-85,774
-60% -$7.38M 0.02% 350
2024
Q3
$17M Sell
142,610
-168
-0.1% -$20K 0.07% 194
2024
Q2
$20.4M Buy
142,778
+18,466
+15% +$2.64M 0.09% 156
2024
Q1
$16.1M Buy
124,312
+16,420
+15% +$2.12M 0.08% 173
2023
Q4
$11.2M Sell
107,892
-4,366
-4% -$452K 0.07% 196
2023
Q3
$10.2M Buy
112,258
+5,326
+5% +$484K 0.04% 188
2023
Q2
$8.65M Buy
106,932
+81,000
+312% +$6.55M 0.01% 198
2023
Q1
$2.07M Sell
25,932
-1,272
-5% -$102K 0.04% 225
2022
Q4
$1.4M Sell
27,204
-4,050
-13% -$208K 0.02% 248
2022
Q3
$1.56M Buy
31,254
+3,958
+15% +$197K 0.02% 252
2022
Q2
$1.49M Buy
27,296
+4,408
+19% +$240K 0.02% 279
2022
Q1
$1.28M Sell
22,888
-3,478
-13% -$195K 0.01% 343
2021
Q4
$1.48M Sell
26,366
-17,222
-40% -$964K 0.01% 352
2021
Q3
$2.09M Buy
43,588
+5,888
+16% +$283K 0.03% 223
2021
Q2
$1.58M Sell
37,700
-5,672
-13% -$238K 0.02% 249
2021
Q1
$1.48M Buy
43,372
+6,148
+17% +$210K 0.02% 219
2020
Q4
$1.3M Buy
37,224
+110
+0.3% +$3.84K 0.02% 207
2020
Q3
$1.29M Sell
37,114
-60
-0.2% -$2.08K 0.02% 205
2020
Q2
$1.22M Buy
37,174
+19,296
+108% +$632K 0.03% 196
2020
Q1
$545K Sell
17,878
-1,892
-10% -$57.7K 0.02% 267
2019
Q4
$572K Buy
19,770
+1,698
+9% +$49.1K 0.02% 278
2019
Q3
$467K Buy
18,072
+1,408
+8% +$36.4K 0.01% 277
2019
Q2
$425K Sell
16,664
-5,084
-23% -$130K 0.01% 271
2019
Q1
$577K Buy
21,748
+16,414
+308% +$435K 0.02% 164
2018
Q4
$123K Buy
+5,334
New +$123K 0.01% 287